BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8785157)

  • 1. Histamine release by neuromuscular blocking agents.
    Todd DB
    Br J Anaesth; 1996 Mar; 76(3):471. PubMed ID: 8785157
    [No Abstract]   [Full Text] [Related]  

  • 2. Histamine-release haemodynamic changes produced by rocuronium, vecuronium, mivacurium, atracurium and tubocurarine.
    Naguib M; Samarkandi AH; Bakhamees HS; Magboul MA; el-Bakry AK
    Br J Anaesth; 1995 Nov; 75(5):588-92. PubMed ID: 7577286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cutaneous reactions secondary to anaesthetic induction with mivacurium].
    Miloudi Y; El Harrar N; Bensaid A; Hussein MA
    Ann Fr Anesth Reanim; 2007; 26(7-8):717. PubMed ID: 17572045
    [No Abstract]   [Full Text] [Related]  

  • 4. Mivacurium. A review of its pharmacology and therapeutic potential in general anaesthesia.
    Frampton JE; McTavish D
    Drugs; 1993 Jun; 45(6):1066-1089. PubMed ID: 7691494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of oral antihistamine premedication on mivacurium-induced histamine release and side effects.
    Doenicke A; Moss J; Lorenz W; Mayer M; Rau J; Jedrzejewski A; Ostwald P
    Br J Anaesth; 1996 Sep; 77(3):421-3. PubMed ID: 8949824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Histamine liberation in the recovery unit after administration of mivacurium by continuous infusion].
    de la Cruz Pérez C; Cruz Mañas J
    Rev Esp Anestesiol Reanim; 1998 Feb; 45(2):77-8. PubMed ID: 9580530
    [No Abstract]   [Full Text] [Related]  

  • 7. The accuracy of the 5%-25% (T1-T3) twitch recovery interval in predicting the speed of spontaneous recovery from mivacurium-induced neuromuscular blockade.
    Savarese JJ; Lien CA; Belmont MR
    Anesth Analg; 1995 Jan; 80(1):209-10. PubMed ID: 7802290
    [No Abstract]   [Full Text] [Related]  

  • 8. Mivacurium block in patients with abnormal plasma cholinesterase.
    Viby-Mogensen J
    Acta Anaesthesiol Scand; 1995 Nov; 39(8):1001-2. PubMed ID: 8607297
    [No Abstract]   [Full Text] [Related]  

  • 9. Interactions between mivacurium and prilocaine.
    Wildsmith JA
    Br J Anaesth; 1997 Aug; 79(2):262. PubMed ID: 9349138
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of hepatic cirrhosis on the pharmacodynamics and pharmacokinetics of mivacurium in humans.
    Levy G
    Pharm Res; 1994 May; 11(5):772-3. PubMed ID: 8058651
    [No Abstract]   [Full Text] [Related]  

  • 11. [The clinical pharmacology of mivacurium].
    Diefenbach C; Mellinghoff H
    Anaesthesist; 1997 May; 46(5):385-8. PubMed ID: 9245207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Newer neuromuscular blocking drugs. An overview of their clinical pharmacology and therapeutic use.
    Mirakhur RK
    Drugs; 1992 Aug; 44(2):182-99. PubMed ID: 1382013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of promethazine or dexamethasone pretreatment on mivacurium-induced histamine release in children.
    Xiang Z; Yan-Liang Q; Xiao-Yang S; Yan-Hui Z; Min C; Guo-Shen G; Ming-Chun W; Zhong-Bing L; Qing-Li W; Guang-Jun H; Ming-Zhe Q; Jun T
    Paediatr Anaesth; 2014 Mar; 24(3):322-6. PubMed ID: 24238032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitivity to mivacurium in a patient with mitochondrial myopathy.
    Naguib M; el Dawlatly AA; Ashour M; al-Bunyan M
    Anesthesiology; 1996 Jun; 84(6):1506-9. PubMed ID: 8669694
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of the neuromuscular blocking properties and side-effects of the two new isoquinolinium bisquaternary compounds (BW.252C64 and BW.403C65).
    Hughes R
    Br J Anaesth; 1972 Jan; 44(1):27-42. PubMed ID: 4109994
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of the effects of mivacurium on the diaphragm and geniohyoid muscles.
    d'Honneur G; Slavov V; Merle JC; Kirov K; Rimaniol JM; Sperry L; Duvaldestin P
    Br J Anaesth; 1996 Dec; 77(6):716-9. PubMed ID: 9014621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic effects of mivacurium chloride administered to patients during oxygen-sufentanil anesthesia for coronary artery bypass grafting or valve replacement.
    Stoops CM; Curtis CA; Kovach DA; McCammon RL; Stoelting RK; Warren TM; Miller D; Bopp SK; Jugovic DJ; Abou-Donia MM
    Anesth Analg; 1989 Mar; 68(3):333-9. PubMed ID: 2465710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacodynamics of mivacurium in children, using a computer-controlled infusion.
    Meretoja OA; Olkkola KT
    Br J Anaesth; 1993 Aug; 71(2):232-7. PubMed ID: 8123398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic carbamazepine therapy does not influence mivacurium-induced neuromuscular block.
    Spacek A; Neiger FX; Spiss CK; Kress HG
    Br J Anaesth; 1996 Oct; 77(4):500-2. PubMed ID: 8942336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy and safety of mivacurium in pediatric patients.
    Zeng R; Liu X; Zhang J; Yin N; Fei J; Zhong S; Hu Z; Hu M; Zhang M; Li B; Li J; Lian Q; ShangGuan W
    BMC Anesthesiol; 2017 Apr; 17(1):58. PubMed ID: 28415988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.